Associate Professor Southern College of Optometry Rossville, Tennessee, United States
Disclosure(s): No financial relationships to disclose
Disclosure(s):
Chris Borgman, OD: No financial relationships to disclose
Optometrists often co-manage patients that have systemic conditions being treated with Plaquenil (hydroxychloroquine). This lecture is designed to review old concepts, new guidelines, and novel approaches in the management of these patients with the goal of preventing toxicity and devastating vision loss.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Review updated screening guidelines for patients on Plaquenil (hydroxychloroquine)
Review foundational anatomic relationships to help identify toxicity earlier
Outline risk factor identification, technology used, and best way to communicate results with prescribing physicians
Discuss cutting-edge thoughts on the management of this disease based on latest literature and research
